Home › Research › Cognitive tests and assessment
Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type
Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N.. Endocrine journal, 1994-08-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
This study was designed to investigate the therapeutic efficacy of estrogen in female patients with dementia of the Alzheimer type (DAT). Fifteen DAT patients with a mean age of (mean +/- SE) 71.9 +/- 2.4 years were treated with 0.625 mg of conjugated equine estrogens orally twice a day for 6 weeks. Of the 15 DAT patients, 4 were diagnosed as mild, 7 as moderate and 4 as severe.
What this study adds
Evidence grade: Low
The record lists 15 participants. This small study treated 15 female Alzheimer's patients with estrogen for 6 weeks and assessed effects using psychometric tests, behavior scales, blood flow measurement and EEG. It is a small, short trial of a possible treatment, not a cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y., & Hagino, N. (1994). Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocrine journal. https://doi.org/10.1507/endocrj.41.361
Vancouver
Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocrine journal. 1994. doi:10.1507/endocrj.41.361. PMID: 8528351.
BibTeX
@article{ohkura1994-8528351,
author = {Ohkura, T. and Isse, K. and Akazawa, K. and Hamamoto, M. and Yaoi, Y. and Hagino, N.},
title = {{Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type}},
journal = {Endocrine journal},
year = {1994},
doi = {10.1507/endocrj.41.361},
pmid = {8528351},
url = {https://doi.org/10.1507/endocrj.41.361}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Fifteen DAT patients with a mean age of (mean +/- SE) 71.9 +/- 2.4 years were treated with 0.625 mg of conjugated equine estrogens orally twice a day for 6 weeks.
- Of the 15 DAT patients, 4 were diagnosed as mild, 7 as moderate and 4 as severe.
- The effects of estrogen on DAT patients were evaluated by psychometric assessments, behavior rating scales, regional cerebral blood flow (rCBF) measurement and quantitative EEG analysis.
- Psychometric assessments consisted of Mini-Mental State Examination (MMSE) and Hasegawa Dementia Scale (HDS).
Why it matters
This small study treated 15 female Alzheimer's patients with estrogen for 6 weeks and assessed effects using psychometric tests, behavior scales, blood flow measurement and EEG. It is a small, short trial of a possible treatment, not a cure or prevention.
Study details
- Participants15
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Endocrine journal) |
| Journal's citation record | 1 / 4 | Endocrine Journal: journal h-index 101 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1994 — older than 20 years, still counted |
| Sample size | 1 / 4 | 15 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 246 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 7.2 citations a year over 34 year(s) since 1994 |
| Impact for its field and year | 3 / 6 | Cited 7.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 6 other studies in this library |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Nobuyoshi Hagino: h-index 18 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Dokkyo University: institution h-index 241 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8528351) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
6 studies in the alzhub library list this one in their references.
Related studies in Cognitive tests and assessment from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.